According to a new report published by AkVis Intelligence, titled, “Women’s Health Devices Market by Type, Application, End Users.: Global Opportunity Analysis and Industry Forecast, 2024–2032,” the global Women’s Health Devices market size was valued at $ 32 Billion in 2023, and is projected to reach $ 55.46 Billion by 2032, registering a CAGR of 6.03% from 2024 to 2032. are the devices being developed to cater to the monthly health issues that women face. Among these are menstrual tracking, pulmonary care, thyroid level detection, weight control, and management of aesthetics and beauty. Outside of the workplace, women's health presents challenges at various stages of life. Thankfully, the healthcare system is evolving to satisfy these needs. To empower women to take charge of their own health, a new generation of health devices is emerging. The goal of these devices is to improve menstrual health, which is an essential aspect of women's healthcare. Trackers monitor cycles, predict ovulation, and identify any potential hormone imbalances. By strengthening the pelvic floor, pelvic floor health devices help address incontinence and enhance sexual function.
seeing exponential growth because of technological advancements and the entry of large IT giants in a number of categories, including wearable medical devices, biosensor-based devices, and in-vitro diagnostics. Every day, something new is invented to improve accessibility and affordability of healthcare. The majority of those in their 20s to 60s are actively changing the healthcare system. Additionally, this has resulted in a substantial change in the medical device development industry. Assisted reproductive technology (ART), minimally invasive surgery (MIS), ultrasound, and genetic testing are a few of the technologies commonly used in women's healthcare.
The showing suggests that DHTs support women in coping with stress, anxiety, depression, and other mental health issues. By means of medication adherence, lifestyle adjustments, and real-time vital sign surveillance, they also enable enhanced self-management. Thorough research carried out in North America and the Middle East has demonstrated the remarkable benefits of these technologies in enhancing the general health of female patients and healthcare providers (through increased productivity and workflow optimisation, easier access to information and decision support, and as a tool for wellness and mental health support). Additionally, these technologies can foster an environment where women feel more equal and empowered to use technology and its devices.
Global Women’s Health Devices Market, Segmentation
The Women’s Health Devices market is segmented on the basis of Type, Application, End Users., and region.
Type:
The type of segment is further classified into Devices (Fetal Monitoring, Mental Health Devices, Pelvic & Uterine Healthcare, General Women Healthcare), Consumables. Among these, the Devices sub-segment accounted for the highest market share in 2023. Another reason is the rising number of diseases specific to women's health. As awareness of women's health issues increases, there will unavoidably be a greater need for diagnostic tools to recognise and address these conditions. Lastly, improved public health education and a growing focus on preventative care are helping people become more aware of the variety of diagnostic tests that are available. This empowers women to make their own health-related decisions and, when required, to seek the tests they need. Improved public health education and rising awareness of preventative care are helping people grasp the variety of diagnostic tests that are accessible. Women now can make more informed decisions regarding their health since they are more aware of their possibilities.
End Users:
The application segment is further classified into Hospitals & clinics, Home Healthcare. Among these, the Hospitals & clinics sub-segment is anticipated to show the fastest growth by 2032. The reason for hospitals' and clinics' dominance in the women's health equipment industry extends beyond simple brand recognition. Simplified treatment, medical knowledge, and regulatory considerations form an intricate web of linked elements. Hospitals and clinics have the infrastructure and trained personnel needed to handle the complexity of various women's health equipment. Think up advanced technologies for foetal screening or monitoring that make advantage of cutting-edge medical technology. Simply said, most homes lack the specialised equipment and understanding required to utilise these devices safely and effectively. Naturally, this creates a barrier to the widespread use of these devices at home.
Region:
The Women’s Health Devices market in North America is projected to show the fastest growth by 2032. North America is home to most of the major players in the women's health device industry. This concentration of leading manufacturers and innovators has several advantages. These companies drive technological innovation, leading to the development of women's health devices that are more effective, enjoyable, and user-friendly. The market offers a wider range of devices to accommodate various demands and preferences because there are numerous competitors. Businesses strive to constantly enhance the features, cost, and quality of their products, which ultimately helps customers. Governments in North America allocate significant funding to women's health initiatives. There are two ways in which this funding impacts the market for women's health equipment. Funding is often used to educate women about the benefits of using these devices for condition and preventative care.
Some of the leading Women’s Health Devices market players are
- Kindbody (North America)
- Maven Clinic (North America)
- Mira Fertility (North America)
- Sprout Wellness (North America)
- Boston Scientific Corporation (North America)
- CooperSurgical Inc. (North America)
- Hologic Inc. (North America)
- GE Healthcare (North America)
- Cardinal Health (North America)
- Carestream Health (North America)
- BD (Becton, Dickinson and Company) (North America)
- Johnson & Johnson (North America)
- Abbott Laboratories (North America)
- Zimmer Biomet (North America)
- Elvie (Europe)
Key Industry Developments
- In April 2024, Elvie, the disruptive global FemTech health and wellness brand, releases "The Motherload: The weight of limited postpartum support," their first-ever report, in partnership with Mother.ly, putting the state of maternal health under the microscope. The study of over 1,000 women with children has uncovered a trio of serious pregnancy and postpartum challenges that mothers currently face.
- In April 2024, MARLBOROUGH, Mass. (BUSINESS WIRE) Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital and other customary closing adjustments.
Key Findings of the Study / Key Industry Developments.
- Hospitals & clinics Segment Held the Largest Share.
- North American is Expected to Dominate the Market Over the Forecast Period.
- Increased Female Disease Requires the Use of Check-Up Instrument
T. Kumbhar
Author Information
T. Kumbhar is a Senior Market Research Consultant at IMR, specializing in Agro-Chemicals, Food Tech, Consumer Goods, and more. With four years of experience, he delivers market insights, competitive analysis, and data-driven business strategies.
